Skip to main content

Advertisement

Table 1 Baseline clinical and radiological characteristics of patients after randomisation in A. paniculata and placebo treatment groups

From: Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study

Parameter   A. paniculata n = 13   Placebo n = 11  
   Mean SD min max   Mean SD min max p-value
Age   35.09 11.79 15 47   38.70 10.65 22 51 0.3066
Sex (w/m)   9/4      7/4     0.5250
Disease duration prior to study (year)   3.62 4.56 0 16   6.00 8.20 0 24 0.8067
Relapse (2 years)   1.73 1.27 1 5   1.46 0.52 1 2 0.9236
EDSS   2.64 1.29 1 5   2.08 1.66 0 6 0.1663
FSS   4,15 1,88 1 6.4   3.76 1.68 1 5.5 0.3990
Gd lesion number 0      0      
Interferon-beta 1a im.(Avonex® 30 mcg) 7      5      
Interferon-beta 1a sc.(Rebif® 44 mcg) 6      6